These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11033118)

  • 1. Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation.
    Babaei S; Picard P; Ravandi A; Monge JC; Lee TC; Cernacek P; Stewart DJ
    Cardiovasc Res; 2000 Oct; 48(1):158-67. PubMed ID: 11033118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of VasoCare therapy on the initiation and progression of atherosclerosis.
    Babaei S; Stewart DJ; Picard P; Monge JC
    Atherosclerosis; 2002 May; 162(1):45-53. PubMed ID: 11947896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids.
    Kowala MC; Grove RI; Aberg G
    Atherosclerosis; 1994 Jul; 108(1):61-72. PubMed ID: 7980708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.
    Moore KJ; Kunjathoor VV; Koehn SL; Manning JJ; Tseng AA; Silver JM; McKee M; Freeman MW
    J Clin Invest; 2005 Aug; 115(8):2192-201. PubMed ID: 16075060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis.
    Patel KM; Strong A; Tohyama J; Jin X; Morales CR; Billheimer J; Millar J; Kruth H; Rader DJ
    Circ Res; 2015 Feb; 116(5):789-96. PubMed ID: 25593281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of endothelin receptors reduces diet-induced hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice.
    Iwasa S; Fan J; Miyauchi T; Watanabe T
    Pathobiology; 2001; 69(1):1-10. PubMed ID: 11641611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice.
    Babaev VR; Patel MB; Semenkovich CF; Fazio S; Linton MF
    J Biol Chem; 2000 Aug; 275(34):26293-9. PubMed ID: 10858435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
    Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
    Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice.
    Leppänen P; Luoma JS; Hofker MH; Havekes LM; Ylä-Herttuala S
    Atherosclerosis; 1998 Jan; 136(1):147-52. PubMed ID: 9544741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis.
    Liu Z; Zhu H; Dai X; Wang C; Ding Y; Song P; Zou MH
    Circ Res; 2017 Oct; 121(9):1047-1057. PubMed ID: 28827412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice.
    Barton M; Haudenschild CC; d'Uscio LV; Shaw S; Münter K; Lüscher TF
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14367-72. PubMed ID: 9826706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of Dioscin on atherosclerosis and foam cell formation in hyperlipidemia rats.
    Wang P; He LY; Shen GD; Li RL; Yang JL
    Inflammopharmacology; 2017 Dec; 25(6):633-642. PubMed ID: 28365854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
    Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression.
    Li Y; Jiang B; Liang P; Tong Z; Liu M; Lv Q; Liu Y; Liu X; Tang Y; Xiao X
    Biochem Biophys Res Commun; 2017 Apr; 486(2):364-371. PubMed ID: 28315324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.